AU2002217999A1
(en)
|
2000-11-01 |
2002-05-15 |
Cor Therapeutics, Inc. |
Process for the production of 4-quinazolinylpiperazin-1-carboxylic acid phenylamides
|
RU2324682C2
(ru)
*
|
2002-10-15 |
2008-05-20 |
Оцука Фармасьютикал Ко., Лтд. |
Производное 1-замещенного 4-нитроимидазола и способ его получения
|
KR100851802B1
(ko)
*
|
2003-10-31 |
2008-08-13 |
오쓰까 세이야꾸 가부시키가이샤 |
결핵의 치료를 위한2,3-디히드로-6-니트로이미다조[2,1-b]옥사졸 화합물
|
JP4761756B2
(ja)
*
|
2003-10-31 |
2011-08-31 |
大塚製薬株式会社 |
2,3−ジヒドロイミダゾ[2,1−b]オキサゾ−ル化合物
|
TWI300409B
(en)
|
2004-02-18 |
2008-09-01 |
Otsuka Pharma Co Ltd |
Method for producing 4-nitroimidazole compound
|
ES2501240T3
(es)
|
2004-03-31 |
2014-10-01 |
Nippon Soda Co., Ltd. |
Compuesto de amina cíclica y agente de control de plagas
|
JP4789966B2
(ja)
*
|
2004-04-09 |
2011-10-12 |
大塚製薬株式会社 |
医薬組成物
|
JP4787529B2
(ja)
*
|
2004-04-09 |
2011-10-05 |
大塚製薬株式会社 |
医薬組成物
|
US7408066B2
(en)
*
|
2005-06-20 |
2008-08-05 |
Schering Corproation |
Carbon-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists
|
MX2008001210A
(es)
*
|
2005-07-28 |
2008-03-24 |
Otsuka Pharma Co Ltd |
Composicion farmaceutica que comprende derivados de 2,3-dihidro-6-nitroimidazo{2,1-b]oxazol.
|
TW201233389A
(en)
*
|
2005-10-05 |
2012-08-16 |
Otsuka Pharma Co Ltd |
Antituberculous therapeutic drugs and kit containing the same
|
JP5105818B2
(ja)
*
|
2005-10-05 |
2012-12-26 |
大塚製薬株式会社 |
医薬組成物
|
CN102936221B
(zh)
*
|
2005-10-06 |
2014-09-10 |
日本曹达株式会社 |
桥联环状胺化合物以及有害生物防除剂
|
TW200800268A
(en)
*
|
2005-11-04 |
2008-01-01 |
Otsuka Pharma Co Ltd |
Medicinal composition showing improved drug absorbability
|
AU2006333522A1
(en)
*
|
2005-12-21 |
2007-07-12 |
Decode Genetics, Ehf. |
Biaryl nitrogen heterocycle inhibitors of LTA4H for treating inflammation
|
JP2009526773A
(ja)
*
|
2006-02-13 |
2009-07-23 |
ラボラトワール セローノ ソシエテ アノニム |
細菌感染症治療のためのスルホンアミド誘導体
|
JP2007297305A
(ja)
*
|
2006-04-28 |
2007-11-15 |
Daiso Co Ltd |
N−(2,3−エポキシ−2−メチルプロピル)フタルイミドの製造法
|
EP2125750B1
(en)
*
|
2007-02-26 |
2014-05-21 |
Vitae Pharmaceuticals, Inc. |
Cyclic urea and carbamate inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
AR070301A1
(es)
*
|
2007-05-08 |
2010-03-31 |
Otsuka Pharma Co Ltd |
Compuesto epoxi y metodo para producir el mismo
|
CL2008002199A1
(es)
*
|
2007-07-26 |
2009-10-23 |
Vitae Pharmaceuticals Inc |
Compuestos derivados de 1,3-oxazin-2-ona; composicion farmaceutica que comprende a dichos compuestos; y uso para tratar una enfermedad asociada con la actividad de la 11beta-hidroxiesteroide deshidrogenasa tipo 1 (11beta-hsd1) tales como dislipidemia, hiperlipidemia, hipertension, obesidad y enfermedad cardiovascular, entre otras.
|
WO2009021965A2
(en)
*
|
2007-08-15 |
2009-02-19 |
Glaxo Group Limited |
Substituted quinoline derivatives as h1 receptor antagonists
|
US20100222349A1
(en)
*
|
2007-10-16 |
2010-09-02 |
Glaxo Group Limited |
Quinoline derivatives used to treat inflammatory and allergic diseases
|
AR069207A1
(es)
*
|
2007-11-07 |
2010-01-06 |
Vitae Pharmaceuticals Inc |
Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
|
JP5490014B2
(ja)
|
2007-12-11 |
2014-05-14 |
ヴァイティー ファーマシューティカルズ,インコーポレイテッド |
11β−ヒドロキシステロイドデヒドロゲナーゼ1型の環状尿素阻害剤
|
TW200934490A
(en)
*
|
2008-01-07 |
2009-08-16 |
Vitae Pharmaceuticals Inc |
Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
|
EP2252601B1
(en)
|
2008-01-24 |
2012-12-19 |
Vitae Pharmaceuticals, Inc. |
Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
CA2714532A1
(en)
*
|
2008-02-11 |
2009-08-20 |
Vitae Pharmaceuticals, Inc. |
1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
|
EP2254872A2
(en)
*
|
2008-02-15 |
2010-12-01 |
Vitae Pharmaceuticals, Inc. |
Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
JP5538356B2
(ja)
*
|
2008-03-18 |
2014-07-02 |
ヴァイティー ファーマシューティカルズ,インコーポレイテッド |
11β−ヒドロキシステロイドデヒドロゲナーゼ1型の阻害剤
|
AU2009228293B2
(en)
*
|
2008-03-26 |
2012-11-08 |
Tennor Therapeutics (Suzhou) Limited |
Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones
|
JP5451752B2
(ja)
*
|
2008-05-01 |
2014-03-26 |
ヴァイティー ファーマシューティカルズ,インコーポレイテッド |
11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状インヒビター
|
BRPI0911764A2
(pt)
*
|
2008-05-01 |
2015-10-06 |
Boehringer Ingelheim Int |
inibidores cíclicos de 11beta-hidroxiesteroide desigrogenase 1
|
CL2009001058A1
(es)
|
2008-05-01 |
2010-09-10 |
Vitae Pharmaceuticals Inc |
Compuestos derivados de oxazinas sustituidas, inhibidores de la 11b-hidroxiesteroide deshidrogenasa de tipo-1; composicion farmaceutica; y uso del compuesto para inhibir la actividad de 11b-hsd1, como en el tratamiento de la diabetes, dislipidemia, hipertension, obesidad, cancer, glaucoma, entre otras.
|
CA2723034A1
(en)
|
2008-05-01 |
2009-11-05 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
US8114868B2
(en)
|
2008-07-25 |
2012-02-14 |
Boehringer Ingelheim International Gmbh |
Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
|
TW201016691A
(en)
|
2008-07-25 |
2010-05-01 |
Boehringer Ingelheim Int |
Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
US9540322B2
(en)
|
2008-08-18 |
2017-01-10 |
Yale University |
MIF modulators
|
EP2326631A4
(en)
*
|
2008-08-18 |
2012-03-21 |
Univ Yale |
MODULATORS OF MIF
|
US9643922B2
(en)
|
2008-08-18 |
2017-05-09 |
Yale University |
MIF modulators
|
EP2323990B1
(en)
|
2008-08-21 |
2014-06-18 |
Dynamit Nobel GmbH Explosivstoff- und Systemtechnik |
Methods for the production of 2-halo-4-nitroimidazole and intermediates thereof
|
WO2010143007A1
(en)
*
|
2009-06-10 |
2010-12-16 |
Dynamit Nobel Gmbh Explosivstoff-Und Systemtechnik |
Method for the production of 2-halogeno-4-nitroimidazole
|
WO2010089303A1
(en)
|
2009-02-04 |
2010-08-12 |
Boehringer Ingelheim International Gmbh |
CYCLIC INHIBITORS OF 11 β-HYDROXYSTEROID DEHYDROGENASE 1
|
TW201039034A
(en)
*
|
2009-04-27 |
2010-11-01 |
Chunghwa Picture Tubes Ltd |
Pixel structure and the method of forming the same
|
KR20120061771A
(ko)
*
|
2009-04-30 |
2012-06-13 |
비타이 파마슈티컬즈, 인코포레이티드 |
11베타-하이드록시스테로이드 탈수소효소 1의 고리형 억제제
|
MA33216B1
(fr)
|
2009-04-30 |
2012-04-02 |
Boehringer Ingelheim Int |
Inhibiteurs cycliques de la 11béta-hydroxysteroïde déshydrogénase 1
|
US8927539B2
(en)
|
2009-06-11 |
2015-01-06 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure
|
WO2011002910A1
(en)
|
2009-07-01 |
2011-01-06 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
ES2536997T3
(es)
*
|
2009-07-31 |
2015-06-01 |
Global Alliance For Tb Drug Development |
Nitroimidazooxazinas y sus usos en el tratamiento antituberculoso
|
US8293734B2
(en)
*
|
2009-07-31 |
2012-10-23 |
Global Alliance For Tb Drug Development |
Nitroimidazooxazine and nitroimidazooxazole analogues and their uses
|
US9198913B2
(en)
|
2009-07-31 |
2015-12-01 |
Global Alliance For Tb Drug Development |
Nitroimidazooxazines and their uses in anti-tubercular therapy
|
US20120219500A1
(en)
|
2009-10-26 |
2012-08-30 |
Fujifilm Ri Pharma Co., Ltd. |
Diagnostic agent for infectious diseases
|
TW201200523A
(en)
|
2010-01-29 |
2012-01-01 |
Otsuka Pharma Co Ltd |
Synthetic intermediate of oxazole compound and method for producing the same
|
GB201012209D0
(en)
*
|
2010-05-31 |
2010-09-08 |
Ge Healthcare Ltd |
In vivo imaging agent
|
EP2582698B1
(en)
|
2010-06-16 |
2016-09-14 |
Vitae Pharmaceuticals, Inc. |
Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
|
EP2585444B1
(en)
|
2010-06-25 |
2014-10-22 |
Boehringer Ingelheim International GmbH |
Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
|
BR112013010021A2
(pt)
|
2010-11-02 |
2019-09-24 |
Boehringer Ingelheim Int |
combinações farmacêuticas para o tratamento de distúrbios metabólicos.
|
JP5916739B2
(ja)
|
2011-04-15 |
2016-05-11 |
大塚製薬株式会社 |
6,7−ジヒドロイミダゾ[2,1−b][1,3]オキサジン化合物
|
JP2015006994A
(ja)
*
|
2011-10-28 |
2015-01-15 |
大正製薬株式会社 |
ジヒドロイミダゾオキサゾール誘導体
|
WO2014014845A1
(en)
|
2012-07-18 |
2014-01-23 |
Vertex Pharmaceuticals Incorporated |
Combination therapy comprising|1 -ethyl-3-[5-[2-{1 -hydroxy-1 -methyl-ethyl}pyrimidin-5-yl]-7-(tetra hydrofuran-2-|yl}-1 h-benzimidazol-2-yl]urea and derivatives thereof to treat mycobacterium|diseases
|
FR3000064A1
(fr)
|
2012-12-21 |
2014-06-27 |
Univ Lille Ii Droit & Sante |
Composes de type spiroisoxazoline ayant une activite potentialisatrice de l'activite d'un antibiotique-composition et produit pharmaceutiques comprenant de tels composes
|
IN2013DE02954A
(no)
|
2013-10-04 |
2015-04-10 |
Council Scient Ind Res |
|
CN103524492A
(zh)
*
|
2013-10-23 |
2014-01-22 |
中国药科大学 |
侧链含硝基咪唑基团取代的喹诺酮类化合物、其制备及用途
|
AR101704A1
(es)
|
2014-08-28 |
2017-01-04 |
Otsuka Pharma Co Ltd |
Compuestos heterocíclicos fusionados
|
WO2016063298A1
(en)
*
|
2014-10-21 |
2016-04-28 |
Council Of Scientific & Industrial Research |
Substituted 1,2,3-triazol-1-yl-methyl-2,3-dihydro-2-methyl-6-nitroimidazo[2,1-b]oxazoles as anti-mycobacterial agents and a process for the preparation thereof
|
CN105732659B
(zh)
*
|
2014-12-12 |
2019-07-16 |
上海阳帆医药科技有限公司 |
硝基咪唑类化合物及其制备方法和在制药中的用途
|
CN107207532B
(zh)
*
|
2015-01-29 |
2019-07-30 |
南京明德新药研发股份有限公司 |
抗肺结核病的硝基咪唑衍生物
|
LT3275862T
(lt)
|
2015-03-27 |
2020-09-25 |
Otsuka Pharmaceutical Co., Ltd. |
1-(4-hidroksifenil)-4-(4-trifluormetoksifenoksi)piperidino arba jo druskos gamybos būdas
|
CN106317072B
(zh)
*
|
2015-06-17 |
2020-03-17 |
盟科医药技术(上海)有限公司 |
用于分枝杆菌感染治疗的杂环化合物及其应用
|
US10851079B2
(en)
|
2016-02-26 |
2020-12-01 |
Otsuka Pharmaceutical Co., Ltd. |
Piperidine derivative
|
CN105859628B
(zh)
*
|
2016-04-19 |
2018-08-07 |
清远职业技术学院 |
一种抗菌化合物对n咪唑苯甲醛缩邻甲苯胺希夫碱及其制备方法和应用
|
JP2019521175A
(ja)
*
|
2016-07-22 |
2019-07-25 |
メッドシャイン ディスカバリー インコーポレイテッド |
ニトロイミダゾール系化合物の結晶形、塩形およびその製造方法
|
SG11202000988RA
(en)
*
|
2017-08-16 |
2020-03-30 |
Glaxosmithkline Ip Dev Ltd |
Novel compounds
|
KR20210019056A
(ko)
|
2018-06-11 |
2021-02-19 |
오츠카 세이야쿠 가부시키가이샤 |
델라마니드 함유 조성물
|
CN109705022A
(zh)
*
|
2018-12-28 |
2019-05-03 |
上海彩迩文生化科技有限公司 |
一种芳香胺中间体的制备方法
|
CN112300192B
(zh)
*
|
2019-08-02 |
2023-08-11 |
南京长澳医药科技有限公司 |
硝基咪唑类化合物及其制备方法和用途
|
CN110483549B
(zh)
*
|
2019-08-30 |
2021-03-05 |
沈阳药科大学 |
一种硝基咪唑吡喃类抗结核药物的制备方法
|
CN110615800A
(zh)
*
|
2019-10-16 |
2019-12-27 |
李丽丽 |
硝基咪唑类化合物及其制备方法和用途
|
CN112156088B
(zh)
*
|
2020-10-30 |
2021-08-31 |
健民药业集团股份有限公司 |
一种化合物在制备结核分枝杆菌抑制剂中的用途
|
CN113603706A
(zh)
*
|
2021-08-04 |
2021-11-05 |
深圳市泰力生物医药有限公司 |
德拉马尼的晶型、含有该晶型的活性药物和药物组合物
|
CN115368252B
(zh)
*
|
2022-09-19 |
2024-01-12 |
西北农林科技大学 |
一种4-胺基酚类衍生物及应用
|
CN116640106B
(zh)
*
|
2023-05-11 |
2024-03-08 |
郑州大学 |
一种苯基哌嗪类化合物及其制备方法、应用
|